Showing session: reset
Endocrine-Related Cancer Research
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Chairperson
Nicholas Mitsiades
Baylor College of Medicine,
- Free
- audio + slides
- Some slides withheld
Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium
Simon Kreutzfeldt
National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany
- Permission not
granted for presentation
p97/VCP: A novel interactor of the sodium iodide symporter, which can be pharmacologically targeted to increase radioiodine uptake in thyroid and breast cancer cells
Alice Fletcher
University of Birmingham, Birmingham, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Novel clinical targets revealed by kinome reprogramming in mutant ESR1 metastatic breast cancer
Derek Dustin
Baylor College of Medicine, Houston, TX, United States
- Permission not
granted for presentation
Preclinical anticancer activity of LSZ102, a novel oral selective estrogen receptor degrader targeting wild-type and mutant ER
Tinya J Abrams
Novartis, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
FOXA1 chromatin binding is regulated by LSD1-mediated methylation in prostate cancer cells
Changmeng Cai
University of Massachusetts Boston, Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
The androgen receptor antagonist darolutamide shows strong antitumor efficacy in patient- and cell line-derived xenograft prostate cancer models
Bernard Haendler
Bayer AG, Berlin, Germany
- Free
- slides video
- audio + slides
- All slides included
PDX models of ER+ endocrine-resistant metastatic breast cancer identify Polo-like kinase 1 (PLK1) as a therapeutic target
Elisabetta Marangoni
Inst. Curie, Paris, France